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Background: Intravenous administration of human umbilical cord blood cells 
(HUCBC) has been shown to improve heatstroke by reducing arterial hypotension as 
well as cerebral ischemia and damage in a rat model. To extend these findings, we 
assessed both hypothalamic neuronal apoptosis and systemic inflammatory 
responses in the presence of HUCBCs or vehicle medium immediately after initia-
tion of heatstroke.
Methods: Anesthetized rats, immediately after the initiation of heat stress, were 
divided into two groups and given either serum-free lymphocyte medium (0.3 mL 
per rat, intravenously) or HUCBCs (5 × 106 in 0.3 mL serum-free lymphocyte medium, 
intravenously). Another group of rats were exposed to room temperature (26ºC) 
and used as normothermic controls. Heatstroke was induced by exposing the anes-
thetized rats to a high ambient temperature of 43ºC for 68 minutes.
Results: After the onset of heatstroke, animals treated with serum-free lymphocyte 
medium displayed hyperthermia, hypotension, bradycardia, hypothalamic neuronal 
apoptosis and degeneration, and up-regulation of systemic inflammatory response 
molecules including serum tumor necrosis factor-alpha, soluble intercellular adhe-
sion molecule-1 and E-selectin. Heatstroke-induced hypotension, bradycardia, 
hypothalamic neuronal apoptosis and degeneration, and increased systemic inflam-
matory response molecules were significantly inhibited by HUCBC treatment. 
Although heatstroke-induced hyperthermia was not affected by HUCBC treatment, 
the serum levels of the anti-inflammatory cytokine interleukin-10 were signifi-
cantly increased by HUCBC therapy during hyperthermia.
Conclusions: These findings suggest that HUCBC transplantation may prevent the 
occurrence of heatstroke by reducing hypothalamic neuronal damage and the 
systemic inflammatory responses.
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1.  Introduction
Based on the understanding of the pathophysiology 
of heatstroke, it has been proposed that heatstroke 
is a form of excessive hyperthermia (core temper-
ature rising above 40ºC) associated with a systemic 
inflammatory response that leads to multi-organ dys-
function in which central nervous system disorders 
predominate.1
It is generally believed that the anterior hy-
pothalamus preoptic area is an essential ther-
moregulatory center in the brain. A recent report 
has demonstrated that heatstroke rats display in-
creased levels of markers for cellular ischemia (e.g. 
glutamate, lactate-to-pyruvate ratio and nitrite) 
and damage (e.g. glycerol), and enhanced expres-
sion of inducible nitric oxide synthase in the hy-
pothalamus.2 In addition, various serum molecules 
including tumor necrosis factor-alpha (TNF-α),3 sol-
uble intercellular adhesion molecule-1 (sICAM-1),4,5 
and E-selectin6−8 have been demonstrated to be 
involved in the pathophysiology of systemic in-
flammatory response syndrome.9−11 Hyperthermia, 
which occurs during heatstroke, may facilitate the 
leakage of endotoxin from the intestine to the sys-
temic circulation and result in excessive activation 
of leukocytes and endothelial cells.1 Thus, heat-
stroke is characterized by the release of TNF-α and 
other cytokines, up-regulation of cell-surface ad-
hesion molecules, and release of soluble cell-
surface adhesion molecules (e.g. E-selectin and 
1CAM-1).
Human umbilical cord blood cells (HUCBCs) 
have emerged as an alternative to bone marrow 
because of their greater availability, lower risk of 
mediating viral transmission, and weaker immuno-
genicity.12 Evidence has accumulated to show that 
HUCBC transplantation is a promising new thera-
peutic method against neurodegenerative diseases 
such as stroke, traumatic brain injury and spinal 
cord injury, as well as blood diseases.13−16 We have 
demonstrated that HUCBC therapy may resuscitate 
rats with heatstroke by reducing circulatory shock 
and cerebral ischemia.17 However, it is unknown 
whether the hypothalamic neuronal damage and 
the systemic inflammatory responses that occur 
during heatstroke can be reduced by HUCBC 
administration.
This study possessed two objectives. The first 
was to assess whether neuronal degeneration and 
apoptosis in the hypothalamus, both of which occur 
during heatstroke, could be reduced by HUCBC 
administration. The second was to assess whether 
heatstroke-induced up-regulation of TNF-α, E-selectin 
and ICAM-1 in the peripheral blood stream could 
be ameliorated by HUCBC administration.
2.  Materials and Methods
2.1.  Animals
Adult Sprague-Dawley rats (weighing 294 ± 15 g) 
were obtained from the Animal Resource Center of 
the National Science Council of the Republic of 
China (Taipei, Taiwan). The animals were housed 
four per group at an ambient temperature (Ta) of 
22 ± 1ºC, with a 12-hour light/dark cycle. Pellet rat 
chow and tap water were available ad libitum. All 
protocols were approved by the Animal Ethics 
Committee of the Chi Mei Medical Center (Tainan, 
Taiwan) in accordance with the Guide for the Care 
and Use of Laboratory Animals of the National 
Institutes of Health, and the guidelines of the 
Animal Welfare Act. Adequate anesthesia was 
maintained to abolish the corneal reflex and pain 
reflexes induced by tail pinching throughout all 
experiments (approximately 8 hours in duration) by 
a single intraperitoneal dose of urethane (1.4 g/kg 
body weight). At the end of the experiments, con-
trol rats and any rats that had survived heatstroke 
were killed with an overdose of urethane.
2.2.  Surgery and physiological parameter 
monitoring
The right femoral artery and vein of rats were 
cannulated with polyethylene tubing (PE50), under 
urethane anesthesia, for blood pressure monitoring 
and drug administration. The core temperature (Tco) 
was monitored continuously by a thermocouple, 
while mean arterial pressure (MAP) and heart rate 
(HR) were monitored continuously with a pressure 
transducer.
2.3.  Induction of heatstroke
The Tco of the anesthetized animals were main-
tained at about 36ºC with an infrared light lamp, 
except during the heat stress experiments. 
Heatstroke was induced by placing the animals in 
a folded heating pad maintained at 43ºC by cir-
culating hot water. The time at which the MAP 
decreased irreversibly from the peak was taken 
as the onset of heatstroke.18 After the onset of 
heatstroke, the heating pad was removed, and 
the animals were allowed to recover at room tem-
perature (26ºC). Our pilot results showed that the 
latency for onset of heatstroke in vehicle-treated 
rats was 68 ± 2 minutes (n = 8). Therefore, in the 
following groups of heatstroke rats, all animals 
were exposed to 43ºC for exactly 68 minutes and 
were then allowed to recover at room temperature 
(26ºC).
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2.4.  Experimental groups
Animals were assigned randomly to one of three 
groups. One group of rats, treated with an intrave-
nous dose of vehicle solution (0.3 mL serum-free 
lymphocyte medium per rat) was exposed to a Ta 
of 26ºC, and the physiological parameters were 
continuously recorded for up to 480 minutes (or to 
the end of the experiments). This group of rats was 
used as normothermic controls. The second group 
was treated with the same dose of vehicle solution 
after the initiation of heat exposure (Ta 43ºC for 
68 minutes) and was used as vehicle-treated heat-
stroke animals. The third group of rats was treated 
with an intravenous dose of HUCBC (5 × 106 in 
0.3 mL serum-free lymphocyte medium) immedi-
ately after the initiation of heat exposure (Ta 43ºC 
for 68 minutes). The last two groups of rats were 
exposed to heat exposure (43ºC) for exactly 68 
minutes to induce heatstroke and were then al-
lowed to recover at room temperature (26ºC). 
Physiological parameters and survival time (inter-
val between the initiation of heat exposure and 
animal death) were observed for up to 480 minutes 
(or to the end of the experiments).
2.5.  Preparation of HUCBCs
Human HUCBCs were obtained from the freshly 
collected buffy coat fraction from healthy donors 
at the Chi Mei Medical Center (Tainan, Taiwan). 
This project was approved by the Institutional 
Review Board of Chi Mei Medical Center. HUCBCs 
were isolated by centrifugation over a Ficoll-Paque 
(Pharmacia, Uppsala, Sweden) density gradient at 
400× g for 30 minutes at room temperature in a 
Sowall RT600 B (Du Pont, CO., Wlimington, DE, USA). 
The cells collected at the interface were washed 
three times in serum-free Roswell Park Memorial 
Institute-1640 (BRL, Grand Island, NY, USA) and sub-
sequently resuspended in serum-free lymphocyte 
medium (Gibco, BRL). For intravenous administra-
tion, a 26-gauge needle was inserted into the rat’s 
tail vein, and cells (0.3 mL) were delivered over a 
1-minute period.
2.6.  Neuronal damage score and apoptosis
At the end of the experiments, animals were killed 
by an overdose of urethane, and the brains were 
fixed in situ and left in the skull in 10% neutral-
buffered formalin for at least 24 hours prior to re-
moval from the skull. The brain was removed and 
embedded in paraffin blocks. Serial sections (10 μm 
thick) through the hypothalamus were stained with 
hematoxylin and eosin for microscopic evaluation. 
The extent of neuronal damage was scored on a 
scale of 0−3, modified from the grading system of 
Pulsinelli et al,19 in which 0 is normal, 1 indicates 
approximately 30% of the neurons are damaged, 2 
indicates that approximately 60% of the neurons 
are damaged, and 3 indicates that 100% of the 
neurons are damaged. Each hemisphere was evalu-
ated independently by an examiner blinded to the 
experimental conditions.
The TUNEL assay was performed using the same 
hypothalamic tissue used in histological verification. 
Color was developed using 3,3-diaminobenzidine 
tetrachloride (Sigma Chemical Co., St. Louis, MO, 
USA). Sections were treated with xylene and etha-
nol to remove paraffin and for dehydration. They 
were then washed with phosphate buffered saline 
(PBS) and incubated in 3% hydrogen peroxide solu-
tion for 20 minutes. The sections were treated with 
5 μg/mL proteinase k for 2 minutes at room tem-
perature, and rewashed in PBS (0.1 M, pH 7.4). The 
sections were then treated with a TUNEL reaction 
mixture (terminal deoxynucleotidyl transferase, 
nucleotide mixture, Roche, Mannheim, Germany) 
at 37ºC for 1 hour, and the sections were washed 
with distilled water. They were then incubated in 
anti-fluorescein, check antibody-conjugated with 
horseradish peroxidase at room temperature for 
30 minutes, washed and visualized using the avadin-
biotin complex (ABC) technique and 0.05% 3,3-
diaminobenzidine tetrachloride as a chromogen. The 
numbers of TUNEL-positive cells were counted by 
a pathologist at 200× magnification, 30 fields per 
section. Blinding was performed for the pathologist’s 
grading of results.
2.7.  Measurement of serum TNF-a,
ICAM-1 and IL-10 levels
Blood samples were collected, immediately sepa-
rated, and stored at −80ºC until they could be 
assayed. We used commercially available ELISA 
kits for the determination of serum TNF-α, ICAM-1 
and IL-10 levels (Quantikine, R&D Systems Inc. 
Minneapolis, MN, USA) according to the manufac-
turer’s instructions.
2.8.  Measurement of E-selectin
Rat peripheral polymorphonuclear (PMN) cells 
were isolated from the whole blood of rats and 
treated with heparin (100 units/mL). Erythrocytes 
were allowed to sediment for 30 minutes after the 
addition of 3 mL of 6% dextran (weight/volume in 
PBS) to 10 mL blood. After sedimentation, the 
plasma containing leukocytes was centrifuged 
twice at 300g for 5 minutes each. The precipitates 
were mixed with 70% osmolality-adjusted Percoll 
and centrifuged at 30,000g for 30 minutes at 26ºC. 
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The PMN-rich layer was fractionated. Each frac-
tion was washed twice with Hanks’ balanced salt 
solution, and the cell number was counted. The 
purity of the PMNs was determined to exceed 95% 
by Giemsa staining. Cells (1 × 106 cells/tube) were 
incubated with a rabbit polyclonal antibody to 
CD62E (ab18981; Abcam PIC332 Cambridge, UK) or 
control. After washing, the cells were stained with 
a secondary antibody (goat polyclonal to rabbit 
IgG-H&L [FITC]•[ab6717]; Abcam PIC). Cells were 
incubated for 1 hour at 4ºC and washed. The cells 
were mixed with oligosaccharides and incubated 
for 20 minutes, and then co-incubated with KM93 
for 60 minutes. The fluorescence intensity of cells 
was analyzed with a FACStar (Becton Dickinson).
2.9.  Statistical analysis
All data are expressed as means ± standard deviation. 
One-way analysis of variance with Tukey’s multiple 
comparisons test was used for serum markers. The 
Wilcoxon test was used for histological as sessment. 
Significant differences were established at p < 0.05. 
For all statistical analyses, SPSS software version 
10.0 (SPSS Inc., Chicago, IL, USA) was used.
3.  Results
3.1.  HUCBC treatment attenuates 
hypotension and improves 
survival during heatstroke
Table 1 summarizes the survival time for vehicle-
treated and HUCBC-treated rats during heatstroke. 
The survival time values were 20−24 minutes (n = 8) 
and 209−237 minutes (n = 8) for vehicle-treated 
and HUCBC-treated rats, respectively. The HUCBC-
treated heatstroke rats had significantly longer 
survival time compared with vehicle-treated heat-
stroke rats (p < 0.05).
Figure 1 shows the effect of heat exposure 
(43ºC for 68 minutes) on Tco, MAP and HR in rats 
treated with vehicle medium and in rats treated 
with HUCBCs. As shown in this figure, 22 minutes 
after the termination of heat exposure in the vehi-
cle-treated group, the values of both MAP and HR 
were significantly lower than those of normothermic 
controls (p < 0.05). On the other hand, the values 
for Tco in the vehicle-treated heatstroke rats were 
significantly higher than those of the normother-
mic controls. Heatstroke-induced hypotension and 
bradycardia, but not hyperthermia, were significantly 
reduced by HUCBC treatment.
3.2.  HUCBC treatment attenuates 
hypothalamic apoptosis and neuronal 
degeneration during heatstroke
Figure 2 summarizes the effects of heat exposure 
on the number of TUNEL-positive cells in the hy-
pothalamus of normothermic controls, vehicle-
treated heatstroke rats, and HUCBC-treated rats. 
At 22 minutes after the onset of heatstroke, the 
number of TUNEL-positive cells of the hypothala-
mus was greater in vehicle-treated heatstroke rats 
than in the normothermic controls. However, in-
crease of TUNEL-positive cells in the hypothalamus 
of heatstroke rats was greatly attenuated by 
HUCBC. A typical example of TUNEL staining of the 
hypothalamus is shown in the top panel of Figure 2.
As shown in Table 2, after the onset of heatstroke, 
the hypothalamic neuronal damage scores were 
higher in animals treated with vehicle compared 
with the normothermic controls. Histo pathological 
verification revealed that heatstroke caused cell 
body shrinkage, pyknosis of the nucleus, loss of Nissl 
substance, and disappearance of the nucleus in the 
hypothalamus of vehicle-treated rats (Figure 3). 
However, HUCBC treatment had neuroprotective 
effects (Figure 3).
3.3.  HUCBC treatment up-regulates serum 
IL-10 levels but down-regulates serum 
E-selectin, ICAM-1 and TNF-a levels 
during heatstroke
Figure 4 shows the serum levels of E-selectin, 
ICAM-1, TNF-α and IL-10 among the three experi-
mental groups. Compared with the normothermic 
controls, vehicle-treated heatstroke rats had 
higher levels of E-selectin, ICAM-1 and TNF-α at 22 
Table 1  Effects of heat exposure (43ºC for 68 minutes) 
on survival time in rats treated with vehicle 
medium or human umbilical cord blood cells 
(5 × 106/0.3 mL, intravenously) immediately 
after the initiation of heat exposure
Treatment group Survival time (min)
Normothermic controls > 480 (n = 8)
Vehicle-treated heatstroke rats* 22 ± 2 (n = 8)†
HUCBC-treated heatstroke rats* 214 ± 23 (n = 8)‡
Except for the normothermic controls, data are means ± stan-
dard deviation followed by the number of animals used in 
parentheses. Group 1 was terminated about 480 minutes 
after the initiation of experiment (or at the end of experi-
ment) by an over-dose of an anesthetic, so they should sur-
vive more than 480 minutes. *For both groups exposed to 
43ºC, the heat stress was withdrawn at 68 minutes and the 
rats were allowed to recover at room temperature (26ºC). 
†p < 0.05 compared with normothermic controls; ‡p < 0.05 
compared with vehicle-treated heatstroke rats; HUCBC = 
human umbilical cord blood cells.
212 W.S. Liu et al
minutes after the onset of heatstroke. The in-
crease in the serum levels of these three markers 
caused by heatstroke were significantly reduced 
by HUCBC therapy. However, compared with the 
vehicle-treated rats, HUCBC-treated rats had 
higher serum levels of IL-10 at 22 minutes after 
the onset of heatstroke.
4.  Discussion
Heatstroke is defined as a condition in which the 
core temperature is elevated to a critical level 
that induces multi-organ damage and dys-
function.20−22 The severity of illness depends on 
the degree of hyperthermia and its duration.23 The 
current approach for treatment of heatstroke is 
whole-body cooling.1 However, heatstroke is often 
fatal following adequate body cooling.24,25 Tissue 
damage continues to develop despite cooling of the 
whole body to the normal body temperature in 25% 
of heatstroke patients.26 It has also been shown 
that normal volunteers can passively endure a core 
temperature of about 42ºC with none or minimal 
tissue injury.27,28 Indeed, as demonstrated in the 
present study, in the absence of whole-body cooling, 
HUCBC treatment significantly prevented the oc-
currence of heatstroke syndromes without affect-
ing the induced hyperthermia. The same contention 
has been previously proposed.29 Thus, it appears 
that tissue ischemia and hypoxia, rather than 
hyperthermia, are the main causes of heatstroke.
Evidence has accumulated to suggest that ther-
moregulatory deficits may occur during heatstroke. 
For example, unanesthetized, unrestrained heat-
stroke mice displayed hypothermia when exposed 
to room temperature.2,30−32 The hypothermia that 
occurred after onset of heatstroke may have re-
sulted from neuronal apoptosis and cell degenera-
tion in the hypothalamus (as demonstrated in the 
present study). In the current study, we also dem-
onstrated the protective effects of HUCBCs in re-
ducing heatstroke-induced hypothalamic neuronal 
apoptosis and degeneration.
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Figure 1 Effects of heat stress (ambient temperature [Ta] 43ºC for 68 minutes) on core temperature, mean arterial 
pressure and heart rate. Open circles, values at Ta of 43ºC in eight rats treated with vehicle immediately after the 
onset of heat exposure. Solid circles, values at Ta of 43ºC in eight rats treated with human umbilical cord blood cells 
(5 ˜  106/0.3 mL, intravenously) immediately after the initiation of heat exposure. Another eight rats were used as 
normothermic controls (solid triangles). Values are means ± standard deviation. *p < 0.05 compared with the normoth-
ermic controls; †p < 0.05 compared with the vehicle-treated group (at 43ºC). HR = heart rate; MAP = mean arterial 
pressure; Ta = ambient temperature; Tco = core temperature.
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Figure 2 Histological examination of neuronal damage. 
The photomicrographs of the hypothalamus in a normo-
thermic control rat (A), a heatstroke rat treated with 
vehicle (B), or a heatstroke rat treated with human 
umbilical cord blood cells (5 ˜  106/0.3 mL, intravenously) 
(C) immediately after the initiation of heat stress. 
Twenty-two minutes after 68-minute heat exposure, the 
hypothalamus of the rat treated with vehicle showed cell 
body shrinkage, pyknosis of the nucleus, loss of Nissl 
substance, and disappearance of the nucleolus (B). By 
contrast, administration of human umbilical cord blood 
cells reduced neuronal damage, as shown in panel C. 
Magnification ˜  400.
HUCBCs have emerged as an alternative to bone 
marrow because of greater availability, weaker im-
munogenicity and lower risk of mediating viral trans-
mission.12 Moreover, HUCBCs are only localized by 
immunohistochemistry and polymerase chain reac-
tion analysis in injured tissue and spleen.33 When 
HUCBCs are transplanted into the neonatal subven-
tricular zone at least some of them differentiate 
into neuronal and glial phenotypes within this neuro-
genic region.34 Upon administration of HUCBCs after 
stroke,13 traumatic brain injury14 and heatstroke,17 
there were significant improvements in behavioral 
indicators or survival. After treatment with HUCBCs, 
the neuronal damage that occurred during heat-
stroke was greatly reduced.17 Future studies are 
required to ascertain whether heatstroke-induced 
hypothalamic neuronal damage can be repaired by 
HUCBC therapy.
The plasma levels of inflammatory cytokines such 
as TNF-α and interleukin-1β are elevated in persons 
with heatstroke.35−38 Studies in rats and rabbits 
have also shown that heatstroke induces systemic 
and brain production of TNF-α and interleukin-
1β.39,40 The increase in the plasma levels of these 
proinflammatory cytokines is associated with the 
severity of heatstroke. Evidence has also suggested 
that IL-10 may have a therapeutic potential in acute 
and chronic inflammatory disease. For example, IL-
10-knockout mice have an increased likelihood of 
inflammatory illness41 and higher mortality rates 
Table 2  Effects of heat exposure (43ºC for 68 min-
utes) on neuronal damage score values of the 
hypothalamus in rats treated with vehicle 
medium or human umbilical cord blood cells 
(5 ˜  106/0.3 mL, intravenously) immediately 
after the initiation of heat exposure
Treatment group
 Neuronal damage 
 score (0−3)
Normothermic controls (0, 0.75)
Vehicle-treated heatstroke rats 2 (2, 2)*
HUCBC-treated heatstroke rats 1 (0.25, 0.75)†
Values are medians with the first and third quartile in paren-
theses for eight rats per group. To determine neuronal dam-
age score, the animals were killed after 68 minutes of heat 
exposure.
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Figure 4 Serum levels of tumor necrosis factor-alpha (TNF-α), intercellular adhesion molecule (ICAM), E-selectin and 
interleukin (IL)-10 among the three experimental groups. *Serum levels of TNF-α, IL-10, E-selectin and ICAM-1 deter-
mined 22 minutes after the termination of heat stress were significantly (p < 0.05; n = 8) increased in vehicle-treated 
rats compared with normothermic controls. †Serum levels of TNF-α, E-selectin and ICAM-1 determined 22 minutes 
after the termination of heat stress were significantly (p < 0.05; n = 8) decreased and the serum levels of IL-10 were 
significantly (p < 0.05; n = 8) increased in heatstroke rats treated with human umbilical cord blood cells (5 ˜  106/0.3 mL, 
intravenously) compared with vehicle controls. HS = heatstroke; HUCBC = human umbilical cord blood cells; ICAM = inter-
cellular adhesion molecule; IL = interleukin; NC = normothermic controls; TNF-α = tumor necrosis factor-alpha.
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Figure 3 TUNEL-positive cells. *The number of TUNEL-
positive cells in the hypothalamic sections 22 minutes 
after the termination of heat stress was significantly 
(p < 0.05; n = 8) increased in vehicle-treated rats compared 
with normothermic controls. †The number of TUNEL-
positive cells in the hypothalamic sections 22 minutes 
after the termination of heat stress was significantly 
(p < 0.05; n = 8) decreased in heatstroke rats treated with 
human umbilical cord blood cells (5 ˜  106/0.3 mL, intra-
venously) compared with vehicle-treated rats. HS = heat-
stroke; HUCBC = human umbilical cord blood cells; 
NC = normothermic controls.
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after experimental sepsis.42 Exogenous administra-
tion of recombinant IL-10 protects mice from lethal 
endotoxemia by reducing TNF- release.43 In endotox-
emic mice, neutralization of endogenously produced 
IL-10 results in an increased production of proin-
flammatory cytokines and enhanced mortality.44 
In the present study, we showed that administration 
of HUCBC increased the serum levels of IL-10 and 
decreased the levels of TNF-α, and prolonged the sur-
vival time during heatstroke. In addition, glucocor-
ticoids,45 interleukin-1 receptor antagonists2 and 
TNF-α may restore tissue blood flow and homeostatic 
function and limit multi-organ dysfunction and death 
in heatstroke. In terms of survival time, our previous 
studies2,45 have shown that cortisone and an IL-1 re-
ceptor antagonist have similar potency to HUCBCs in 
treating heatstroke. Therefore, we need to evalu-
ate the therapeutic effects of the combination of 
HUCBCs and anti-inflammatory or anti-cytokine drugs 
during heatstroke in future studies.
TNF-α plays critical roles as a mediator of inflam-
matory responses.3 The expression of adhesion mol-
ecules is also induced by TNF-α, resulting in increased 
leukocyte-endothelial adherence and activation of 
leukocytes.46 Activation of leukocyte adhesion to the 
endothelium and migration of leukocytes into the 
tissue where cytotoxic chemicals are released causes 
tissue injury.47 The adhesion molecule ICAM-1 me-
diates firm adhesion between leukocytes and en-
dothelial cells and contributes to the migration of 
leukocytes from post-capillary venues into the reper-
fused tissue.47,48 During inflammation, endothelial 
cells express ICAM-1, which initiates adhesion and 
transendothelial migration of circulating leuko-
cytes.47 The serum TNF-α and ICAM-1 levels can be 
considered as markers for the systemic inflammatory 
response because they indirectly reflect the whole-
body production of TNF-α and ICAM-1 in various 
organs.46,49−51 CD62E (E-selectin) is an endothelial 
cell-specific selectin that is expressed on cytokine-
induced endothelial cells only after activation by 
proinflammatory cytokines.52,53 E-selectin has been 
associated with the blood vessel endothelium in di-
verse inflammatory situations.54 Yoshida et al re-
ported that E-selectin expressed in endothelial cells 
becomes associated with the actin cytoskeleton dur-
ing leukocyte adhesion, suggesting that E-selectin 
engages in transmembrane signaling upon ligand 
binding.55 The serum levels of TNF-α, E-selectin and 
ICAM-1 were upregulated in patients with heatstroke.1 
The present results further demonstrated that the 
increased serum levels of these molecules during 
heatstroke in a rat model could be significantly re-
duced by HUCBC treatment. Considering these 
observations together, it is apparent that the heat-
stroke-induced systemic inflammatory response 
can be attenuated by HUCBC therapy.
5.  Conclusions
In summary, our results demonstrate that, in the 
absence of whole-body cooling, HUCBC treatment 
significantly prevents the occurrence of heatstroke 
syndrome without affecting the induced hyperther-
mia. Heatstroke-induced hypothalamic neuronal 
apoptosis and degeneration, and the systemic inflam-
mation response (as demonstrated by increased 
serum levels of TNF-α, E-selectin and ICAM-1) can be 
significantly prevented by HUCBC treatment. These 
findings indicate that HUCBC transplantation may 
improve heat tolerance by reducing the occurrence 
of hypothalamic neuronal apoptosis and degenera-
tion, and the systemic inflammatory response.
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